DOCK9 and breast carcinoma: Intercalation and adhesion assays showed that breast cancer cells depleted of DOCK9 adhere to BEC as efficiently as control cells; however, they show a significant delay in intercalation compared to control cells at the time point where ≥ 50% control cells have intercalated (T50) (Fig. 5f–h).